| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Reproductive Endocrinology |
Medical Research Council Group in Molecular Endocrinology, Centre Hospitalier de lUniversite Laval Research Center, Le Centre Hospitalier Universitaire de Québec, and Laval University, Québec, G1V 4G2, Canada
Address all correspondence and requests for reprints to: Fernand Labrie, Laboratory of Molecular Endocrinology, CHUL Research Center, 2705 Laurier Boulevard, Québec, QC, G1V 4G2, Canada.
This study analyzes in detail the serum concentration of the active
androgens and estrogens, as well as a series of free and conjugated
forms of their precursors and metabolites, after daily application for
2 weeks of 10 mL 20% dehydroepiandrosterone (DHEA) solution on the
skin to avoid first passage through the liver. In men, DHEA
administration caused 175%, 90%, 200% and 120% increases in the
circulating levels of DHEA and its sulfate (DHEA-S), DHEA-fatty acid
esters, and androst-5-ene-3ß,17ß-diol, respectively, with a return
to basal values 7 days after cessation of the 14-day treatment. Serum
androstenedione increased by approximately 80%, whereas serum
testosterone and dihydrotestosterone (DHT) remained unchanged. In
parallel with the changes in serum DHEA, the concentrations of the
conjugated metabolites of DHT, namely androsterone glucuronide,
androstane-3
,17ß-diol-G, and androstane-3ß,17ß-diol-G
increased by about 75%, 50%, and 75%, respectively, whereas
androsterone-sulfate increased 115%. No consistent change was observed
in serum estrone (E1) or estradiol (E2) in men
receiving DHEA, whereas serum E1-sulfate and
E2-sulfate were slightly and inconsistently increased by
about 20%, and serum cortisol and aldosterone concentrations were
unaffected by DHEA administration. Almost superimposable results were
obtained in women for most steroids except testosterone, which was
about 50% increased during DHEA treatment. This increase corresponded
to about 0.8 nM testosterone, an effect undetectable in men
because they already have much higher (
15 nM) basal
testosterone levels. In women, the serum levels of the conjugated
metabolites of DHT, namely androsterone glucuronide,
androstane-3
,17ß-diol-G, androstane-3ß,17ß-diol-G, and
androsterone-sulfate were increased by 125%, 140%, 120% and 150%,
respectively. The present study demonstrates that the serum
concentrations of testosterone, DHT, E1, and E2
are poor indicators of total androgenic and estrogenic activity.
However, the esterified metabolites of DHT appear as reliable markers
of the total androgen pool, because they directly reflect the
intracrine formation of androgens in the tissues possessing the
steroidogenic enzymes required to transform the inactive precursors
DHEA and DHEA-S into DHT. As well demonstrated in women, who synthesize
almost all their androgens from DHEA and DHEA-S, supplementation with
physiological amounts of exogeneous DHEA permits the biosynthesis of
androgens limited to the appropriate target tissues without leakage of
significant amounts of active androgens into the circulation. This
local or intracrine biosynthesis and action of androgens eliminates the
inappropriate exposure of other tissues to androgens and thus minimizes
the risks of undesirable masculinizing or other androgen-related side
effects of DHEA.
This article has been cited by other articles:
![]() |
L. Vandenput, D. Mellstrom, M. Lorentzon, C. Swanson, M. K. Karlsson, J. Brandberg, L. Lonn, E. Orwoll, U. Smith, F. Labrie, et al. Androgens and Glucuronidated Androgen Metabolites Are Associated with Metabolic Risk Factors in Men J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4130 - 4137. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Swanson, M. Lorentzon, L. Vandenput, F. Labrie, A. Rane, J. Jakobsson, S. Chouinard, A. Belanger, and C. Ohlsson Sex Steroid Levels and Cortical Bone Size in Young Men Are Associated with a Uridine Diphosphate Glucuronosyltransferase 2B7 Polymorphism (H268Y) J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3697 - 3704. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Panjari and S. R. Davis DHEA therapy for women: effect on sexual function and wellbeing Hum. Reprod. Update, May 1, 2007; 13(3): 239 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Gracia, E. W. Freeman, M. D. Sammel, H. Lin, and M. Mogul Hormones and Sexuality During Transition to Menopause Obstet. Gynecol., April 1, 2007; 109(4): 831 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Pino, J. M. Rodriguez, S. Rios, P. Astudillo, L. Leiva, G. Seitz, M. Fernandez, and J P. Rodriguez Aromatase activity of human mesenchymal stem cells is stimulated by early differentiation, vitamin D and leptin J. Endocrinol., December 1, 2006; 191(3): 715 - 725. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Basaria and A. S. Dobs Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4743 - 4752. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Caron, B. Cariou, and B. Staels FXR: More than a Bile Acid Receptor? Endocrinology, September 1, 2006; 147(9): 4022 - 4024. [Full Text] [PDF] |
||||
![]() |
C. M. Jankowski, W. S. Gozansky, R. S. Schwartz, D. J. Dahl, J. M. Kittelson, S. M. Scott, R. E. Van Pelt, and W. M. Kohrt Effects of Dehydroepiandrosterone Replacement Therapy on Bone Mineral Density in Older Adults: A Randomized, Controlled Trial J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2986 - 2993. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Labrie Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA. Endocr. Relat. Cancer, June 1, 2006; 13(2): 335 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
V Rochira, A Balestrieri, B Madeo, L Zirilli, A R M Granata, and C Carani Osteoporosis and male age-related hypogonadism: role of sex steroids on bone (patho)physiology Eur. J. Endocrinol., February 1, 2006; 154(2): 175 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Labrie, V Luu-The, A Belanger, S-X Lin, J Simard, G Pelletier, and C Labrie Is dehydroepiandrosterone a hormone? J. Endocrinol., November 1, 2005; 187(2): 169 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Davis, S. L. Davison, S. Donath, and R. J. Bell Circulating Androgen Levels and Self-reported Sexual Function in Women JAMA, July 6, 2005; 294(1): 91 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Simard, M.-L. Ricketts, S. Gingras, P. Soucy, F. A. Feltus, and M. H. Melner Molecular Biology of the 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase Gene Family Endocr. Rev., June 1, 2005; 26(4): 525 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Schmidt, R. C. Daly, M. Bloch, M. J. Smith, M. A. Danaceau, L. Simpson St. Clair, J. H. Murphy, N. Haq, and D. R. Rubinow Dehydroepiandrosterone Monotherapy in Midlife-Onset Major and Minor Depression Arch Gen Psychiatry, February 1, 2005; 62(2): 154 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Blouin, S. Blanchette, C. Richard, P. Dupont, V. Luu-The, and A. Tchernof Expression and activity of steroid aldoketoreductases 1C in omental adipose tissue are positive correlates of adiposity in women Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E398 - E404. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Christiansen, C. H. Gravholt, S. Fisker, N. Moller, M. Andersen, B. Svenstrup, P. Bennett, P. Ivarsen, J. S. Christiansen, and J. O. L. Jorgensen Very short term dehydroepiandrosterone treatment in female adrenal failure: impact on carbohydrate, lipid and protein metabolism Eur. J. Endocrinol., January 1, 2005; 152(1): 77 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gennari, R. Nuti, and J. P. Bilezikian Aromatase Activity and Bone Homeostasis in Men J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 5898 - 5907. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Leblanc, M.-C. Belanger, P. Julien, A. Tchernof, C. Labrie, A. Belanger, and F. Labrie Plasma Lipoprotein Profile in the Male Cynomolgus Monkey under Normal, Hypogonadal, and Combined Androgen Blockade Conditions J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1849 - 1857. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kuuranne, M. Kurkela, M. Thevis, W. Schanzer, M. Finel, and R. Kostiainen GLUCURONIDATION OF ANABOLIC ANDROGENIC STEROIDS BY RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES Drug Metab. Dispos., September 1, 2003; 31(9): 1117 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Leblanc, C. Labrie, A. Belanger, B. Candas, and F. Labrie Bioavailability and Pharmacokinetics of Dehydroepiandrosterone in the Cynomolgus Monkey J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4293 - 4302. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fassnacht, N. Schlenz, S. B. Schneider, S. A. Wudy, B. Allolio, and W. Arlt Beyond Adrenal and Ovarian Androgen Generation: Increased Peripheral 5{alpha}-Reductase Activity in Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2760 - 2766. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Labrie, V. Luu-The, C. Labrie, A. Belanger, J. Simard, S.-X. Lin, and G. Pelletier Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone Endocr. Rev., April 1, 2003; 24(2): 152 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lovas, G. Gebre-Medhin, T. S. Trovik, K. J. Fougner, S. Uhlving, B. G. Nedrebo, O. L. Myking, O. Kampe, and E. S. Husebye Replacement of Dehydroepiandrosterone in Adrenal Failure: No Benefit for Subjective Health Status and Sexuality in a 9-Month, Randomized, Parallel Group Clinical Trial J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1112 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. McTernan, L. A. Anderson, A. J. Anwar, M. C. Eggo, J. Crocker, A. H. Barnett, P. M. Stewart, and S. Kumar Glucocorticoid Regulation of P450 Aromatase Activity in Human Adipose Tissue: Gender and Site Differences J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1327 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Simpson and M. Dowsett Aromatase and Its Inhibitors: Significance for Breast Cancer Therapy Recent Prog. Horm. Res., January 1, 2002; 57(1): 317 - 338. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Simpson and S. R. Davis Minireview: Aromatase and the Regulation of Estrogen Biosynthesis--Some New Perspectives Endocrinology, November 1, 2001; 142(11): 4589 - 4594. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Arlt, F. Callies, I. Koehler, J. C. van Vlijmen, M. Fassnacht, C. J. Strasburger, M. J. Seibel, D. Huebler, M. Ernst, M. Oettel, et al. Dehydroepiandrosterone Supplementation in Healthy Men with an Age-Related Decline of Dehydroepiandrosterone Secretion J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4686 - 4692. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Crone, G. Gabriel, and T. N. Wise Non-Herbal Nutritional Supplements--The Next Wave: A Comprehensive Review of Risks and Benefits for the C-L Psychiatrist Psychosomatics, August 1, 2001; 42(4): 285 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mazat, S. Lafont, C. Berr, B. Debuire, J.-F. Tessier, J.-F. Dartigues, and E.-E. Baulieu Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: Relationship to gender, subjective health, smoking habits, and 10-year mortality PNAS, June 20, 2001; (2001) 121177998. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Simpson and S. R. Davis Another role highlighted for estrogens in the male: Sexual behavior PNAS, December 8, 2000; (2000) 11526097. [Full Text] |
||||
![]() |
O. Barbier, H. Lapointe, M. El Alfy, D. W. Hum, and A. Bélanger Cellular Localization of Uridine Diphosphoglucuronosyltransferase 2B Enzymes in the Human Prostate by in Situ Hybridization and Immunohistochemistry J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4819 - 4826. [Abstract] [Full Text] |
||||
![]() |
A. W. van den Beld, F. H. de Jong, D. E. Grobbee, H. A. P. Pols, and S. W. J. Lamberts Measures of Bioavailable Serum Testosterone and Estradiol and Their Relationships with Muscle Strength, Bone Density, and Body Composition in Elderly Men J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3276 - 3282. [Abstract] [Full Text] |
||||
![]() |
C. Albert, O. Barbier, M. Vallee, G. Beaudry, A. Belanger, and D. W. Hum Distribution of Uridine Diphosphate-Glucuronosyltransferase (UGT) Expression and Activity in Cynomolgus Monkey Tissues: Evidence for Differential Expression of Steroid-Conjugating UGT Enzymes in Steroid Target Tissues Endocrinology, July 1, 2000; 141(7): 2472 - 2480. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Jarrar, P. Wang, W. G. Cioffi, K. I. Bland, and I. H. Chaudry Mechanisms of the Salutary Effects of Dehydroepiandrosterone After Trauma-Hemorrhage: Direct or Indirect Effects on Cardiac and Hepatocellular Functions? Arch Surg, April 1, 2000; 135(4): 416 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Guillemette, R. C. Millikan, B. Newman, and D. E. Housman Genetic Polymorphisms in Uridine Diphospho-Glucuronosyltransferase 1A1 and Association with Breast Cancer among African Americans Cancer Res., February 1, 2000; 60(4): 950 - 956. [Abstract] [Full Text] |
||||
![]() |
E. M Rocha, L A. Wickham, L. A da Silveira, K. L Krenzer, F.-S. Yu, I. Toda, B. D Sullivan, and D. A Sullivan Identification of androgen receptor protein and 5alpha -reductase mRNA in human ocular tissues Br. J. Ophthalmol., January 1, 2000; 84(1): 76 - 84. [Abstract] [Full Text] |
||||
![]() |
G. A. Brown, M. D. Vukovich, R. L. Sharp, T. A. Reifenrath, K. A. Parsons, and D. S. King Effect of oral DHEA on serum testosterone and adaptations to resistance training in young men J Appl Physiol, December 1, 1999; 87(6): 2274 - 2283. [Abstract] [Full Text] [PDF] |
||||
![]() |
Estrogen: Consequences and Implications of Human Mutations in Synthesis and Action J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4677 - 4694. [Abstract] [Full Text] |
||||
![]() |
O. Barbier, E. Lévesque, A. Bélanger, and D. W. Hum UGT2B23, a Novel Uridine Diphosphate-Glucuronosyltransferase Enzyme Expressed in Steroid Target Tissues That Conjugates Androgen and Estrogen Metabolites Endocrinology, December 1, 1999; 140(12): 5538 - 5548. [Abstract] [Full Text] |
||||
![]() |
S. Gingras and J. Simard Induction of 3{beta}-Hydroxysteroid Dehydrogenase/ Isomerase Type 1 Expression by Interleukin-4 in Human Normal Prostate Epithelial Cells, Immortalized Keratinocytes, Colon, and Cervix Cancer Cell Lines Endocrinology, October 1, 1999; 140(10): 4573 - 4584. [Abstract] [Full Text] |
||||
![]() |
W. Arlt, F. Callies, J. C. van Vlijmen, I. Koehler, M. Reincke, M. Bidlingmaier, D. Huebler, M. Oettel, M. Ernst, H. M. Schulte, et al. Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency N. Engl. J. Med., September 30, 1999; 341(14): 1013 - 1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Rosen Serum Insulin-like Growth Factors and Insulin-like Growth Factor-binding Proteins: Clinical Implications Clin. Chem., August 1, 1999; 45(8): 1384 - 1390. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Arlt, J. Haas, F. Callies, M. Reincke, D. Hübler, M. Oettel, M. Ernst, H. M. Schulte, and B. Allolio Biotransformation of Oral Dehydroepiandrosterone in Elderly Men: Significant Increase in Circulating Estrogens J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2170 - 2176. [Abstract] [Full Text] |
||||
![]() |
J. Pritchard, J.-P. Després, J. Gagnon, A. Tchernof, A. Nadeau, A. Tremblay, and C. Bouchard Plasma Adrenal, Gonadal, and Conjugated Steroids before and after Long Term Overfeeding in Identical Twins J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3277 - 3284. [Abstract] [Full Text] |
||||
![]() |
W. Arlt, H.-G. Justl, F. Callies, M. Reincke, D. Hübler, M. Oettel, M. Ernst, H. M. Schulte, and B. Allolio Oral Dehydroepiandrosterone for Adrenal Androgen Replacement: Pharmacokinetics and Peripheral Conversion to Androgens and Estrogens in Young Healthy Females after Dexamethasone Suppression J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1928 - 1934. [Abstract] [Full Text] |
||||
![]() |
E. R. Simpson and S. R. Davis Another role highlighted for estrogens in the male: Sexual behavior PNAS, December 19, 2000; 97(26): 14038 - 14040. [Full Text] [PDF] |
||||
![]() |
L. Mazat, S. Lafont, C. Berr, B. Debuire, J.-F. Tessier, J.-F. Dartigues, and E.-E. Baulieu Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: Relationship to gender, subjective health, smoking habits, and 10-year mortality PNAS, July 3, 2001; 98(14): 8145 - 8150. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |